STAFF

Dr. Pablo García Valtanen

Viral Immunology & Therapeutics

]

Unit
Preclinical biotechnology

^

Subunit
Anti-infective strategies

Group
Viral Immunology & Therapeutics

+ 34 966 65 87 63

RESEARCH FIELDS

  • Nucleic acid vaccine development.
  • Human herpesviruses and respiratory viruses.
  • Antigen-specific immune responses to viral pathogens.
  • Relevant fields: Human and animal viral immunology and vaccinology.

  • Analytical skills: Vaccine design, flow cytometry-based immune phenotyping, Surface plasmon resonance-based binding studies, chromatography, recombinant virus design and construction, virological and cell culture techniques.

PROFESSIONAL BACKGROUND

  • Postdoctoral positions:
    1. Research Fellow / The University of Adelaide-Queen Elisabeth Hospital/ Australia (2021)          2. Research Fellow – Industry-funded project / University of South Australia – Niumed Ltd Pty/Australia (2017-2021)                                                                                                                           3. Research Associate / University of South Australia/Australia (2015-2021)                                                                                                                  
  • Master’s in Environmental Science – University of New South Wales, Australia (2010)
  • PhD in Cell and Molecular Biology Doctorate Program at IDiBE (2010-2014)
  • Degree in Biology, – Universidad de Alicante (2006)

FUNDING

PABLO GARCÍA VALTANEN

REPRESENTATIVE PUBLICATIONS

Garcia-Valtanen, P. et al. (2022)

Cell Reports Medicine, DOI:https://doi.org/10.1016/j.xcrm.2022.100651

SARS-CoV-2 Omicron variant escapes neutralizing antibodies and T cell responses more efficiently than other variants in mild COVID-19 convalescents.

Perkins GB et al. (2022)

Kidney Int., DOI: https://doi.org/10.1016/j.kint.2022.02.015

Concurrent vaccination of kidney transplant recipients and close household cohabitants against COVID-19.

Ryan FJ. et al. (2022)

BMC Med. , DOI: 10.1186/s12916-021-02228-6

Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection.

GARCIA-VALTANEN, P. ET AL. (2020)

Viruses, DOI: https://doi.org/10.3390/v12050569

Polyinosinic: Polycytidylic Acid and Murine Cytomegalovirus Modulate Expression of Murine IL-10 and IL-21 in White Adipose Tissue.